Risk factors for pancreatic neuroendocrine tumors a clinic-based case-control study

Pancreas

Volumn 43, Issue 8, 2014, Pages 1219-1222

  Halfdanarson, Thorvardur R ^a   Bamlet, William R ^b   McWilliams, Robert R ^b   Hobday, Timothy J ^b   Burch, Patrick A ^b   Rabe, Kari G ^b   Petersen, Gloria M ^b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Carcinoid tumors; Islet cell tumors; Neuroendocrine tumors; Pancreatic neuroendocrine tumors; Risk factors

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; GALLBLADDER CANCER; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; OVARY CANCER; PANCREAS ADENOCARCINOMA; PANCREATIC NEUROENDOCRINE TUMOR; QUESTIONNAIRE; RACE DIFFERENCE; SEX DIFFERENCE; SMOKING; STOMACH CANCER; AGED; COMORBIDITY; DISEASE PREDISPOSITION; DRINKING BEHAVIOR; MIDDLE AGED; NEOPLASTIC SYNDROMES, HEREDITARY; NEUROENDOCRINE TUMORS; OBESITY; PANCREATIC NEOPLASMS; REGISTER; RISK FACTOR;

AGED; ALCOHOL DRINKING; CASE-CONTROL STUDIES; COMORBIDITY; DIABETES MELLITUS; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASTIC SYNDROMES, HEREDITARY; NEUROENDOCRINE TUMORS; OBESITY; PANCREATIC NEOPLASMS; REGISTRIES; RISK FACTORS; SMOKING; SURVEYS AND QUESTIONNAIRES;

EID: 84916594530     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0000000000000234     Document Type: Article

References (19)

1. Halfdanarson TR, Rubin J, Farnell M.B., et al. Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors. Endocr Relat Cancer. 2008; 15:409-427.
2. Strosberg JR, Halfdanarson TR. Survival analyses of pancreatic neuroendocrine tumors: contrasting institutional databases with population-based studies. Presented at the 2010 North American Neuroendocrine Tumor Society (NANETS) Meeting, Santa Fe, New Mexico. 2010.
3. Strosberg JR, Cheema A, Weber J., et al. Prognostic validity of a novel American Joint Committee on Cancer Staging Classification for pancreatic neuroendocrine tumors. J Clin Oncol. 2011; 29:3044-3049.
4. Bilimoria KY, Bentrem DJ, Merkow R.P., et al. Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors. J Am Coll Surg. 2007; 205:558-563.
5. Halfdanarson TR, Rabe KG, Rubin J, et al. Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival. Ann Oncol. 2008; 19:1727-1733.
6. Lakhani VT, You YN, Wells SA. The multiple endocrine neoplasia syndromes. Annu Rev Med. 2007; 58:253-265.
7. Lonser RR, Glenn GM, Walther M, et al. von Hippel-Lindau disease. Lancet. 2003; 361:2059-2067.
8. Hassan MM, Phan A, Li D., et al. Family history of cancer and associated risk of developing neuroendocrine tumors: a case-control study. Cancer Epidemiol Biomarkers Prev. 2008; 17:959-965.
9. Hiripi E, Bermejo JL, Sundquist J, et al. Familial gastrointestinal carcinoid tumours and associated cancers. Ann Oncol. 2009; 20:950-954.
10. Gullo L, Migliori M, Falconi M., et al. Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study. Am J Gastroenterol. 2003; 98: 2435-2439.
11. Hassan MM, Phan A, Li D., et al. Risk factors associated with neuroendocrine tumors: a U.S.-based case-control study. Int J Cancer. 2008; 123:867-873.
12. Kaerlev L, Teglbjaerg PS, Sabroe S, et al. The importance of smoking and medical history for development of small bowel carcinoid tumor: a European population-based case-control study. Cancer Causes Control. 2002; 13:27-34.
13. Halfdanarson TR, Wang L, Bamlet W.R., et al. Mitochondrial genetic polymorphisms do not predict survival in patients with pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2008; 17:2512-2513.
14. McWilliams RR, Bamlet WR, de Andrade M, et al. Nucleotide excision repair pathway polymorphisms and pancreatic cancer risk: evidence for role of MMS19L. Cancer Epidemiol Biomarkers Prev. 2009; 18:1295-1302.
15. Grant CS. Insulinoma. Best Pract Res Clin Gastroenterol. 2005; 19: 783-798.
16. Wilson SD, Doffek KM, Krzywda E.A., et al. Zollinger-Ellison syndrome associated with a history of alcohol abuse: coincidence or consequence? Surgery. 2011; 150:1129-1135.
17. Chen CC, Neugut AI, Rotterdam H. Risk factors for adenocarcinomas and malignant carcinoids of the small intestine: preliminary findings. Cancer Epidemiol Biomarkers Prev. 1994; 3:205-207.
18. Feldman JM, Plonk JW, Bivens C.H., et al. Glucose intolerance in the carcinoid syndrome. Diabetes. 1975; 24:664-671.
19. Pannala R, Basu A, Petersen G.M., et al. New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol. 2009; 10:88-95.